This site is intended for healthcare professionals
News

Phase III Measure Up 1 and Measure Up 2 studies support applications to FDA and MAA for Rinvoq in atopic dermatitis.- AbbVie

Read time: 1 mins
Last updated:30th Oct 2020
Published:30th Oct 2020
Condition: Atopic Dermatitis (Eczema)
Type: drug
Register free for full access to medthority.com